Whatever the precise mechanisms are by which high-dose icosapent ethyl exerts its effects, they do not undermine a highly significant clinical benefit in reducing the residual cardiovascular risk in hypertriglyceridemic patients presenting with concomitant metabolic disorders.
← all excerpts
Cardioprotective Effects of Nutraceuticals: Focus on Omega-3 Polyunsaturated Fatty Acids.
1
—
—